Truzen Lifesciences Private Limited
Pharmaceutical company selling, buying, and exporting drugs and formulations.
2019 | Chennai, Tamil Nadu (India) | Active
Truzen Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -81.32%
- Profit Growth 92.89%
- Ebitda 98.26%
- Net Worth -1.44%
- Total Assets 5.91%
About Truzen Lifesciences
Truzen Lifesciences Private Limited (TLPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 September 2019 (Five years and five months 1 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gopalachari Kannan and Ranganathan Kannan serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397TN2019PTC131829
- Company No.
131829
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Sep 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Pharma
Who are the key members and board of directors at Truzen Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopalachari Kannan  | Director | 27-Sep-2019 | Current |
| Ranganathan Kannan | Director | 27-Sep-2019 | Current |
Financial Performance of Truzen Lifesciences.
Truzen Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 81.32% decrease. The company also saw a substantial improvement in profitability, with a 92.89% increase in profit. The company's net worth dipped by a decrease of 1.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Truzen Lifesciences?
Unlock access to Truzen Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Shri Ganesh Associates Pharmaceuticals Private Limited
Gopalachari Kannan and Ranganathan Kannan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Truzen Lifesciences?
Unlock and access historical data on people associated with Truzen Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Truzen Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Truzen Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.